Showing results (211-220 of 822) with videos related to

Sort By:
Pageof 83
The American Journal of Cardiology|September 19, 1997
A new approach for DDD(R) pacing using a single-pass DDD leadB Naegeli, E Straumann, A Gerber, et al.
Diabetes Care|May 27, 2004
Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetesJulio Rosenstock, Joseph C Cappelleri, Björn Bolinder, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 14, 2014
[Drug reactions caused by chemotherapy agents]L M Ehmann, H Schrumpf, P A Gerber, et al.
Archives of Internal Medicine|July 1, 1985
Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrierS N Thung, M A Gerber, F Klion, et al.
Gastroenterology|May 1, 1987
Cytopathic liver injury in acute delta virus hepatitisJ H Lefkowitch, H Goldstein, R Yatto, et al.
British Journal of Anaesthesia|November 7, 2000
Remifentanil inhibits muscular more than cutaneous pain in humansM Curatolo, S Petersen-Felix, A Gerber, et al.
The American Journal of Pathology|August 1, 1990
Detection of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver tissue by the polymerase chain reactionP Lampertico, J S Malter, M Colombo, et al.
Zeitschrift Fur Kardiologie|November 1, 2005
[Cost-effectiveness of prevention of coronary disease in Germany]K W Lauterbach, A Gerber, G Klever-Deichert, et al.
Dermatology (Basel, Switzerland)|February 25, 2011
Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitorsPeter A Gerber, Gabriela Kukova, Bettina A Buhren, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 15, 2010
[Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects]P A Gerber, B A Buhren, S Kürle, et al.
Pageof 83